Gene discovery could lead to male contraceptive

April 2, 2009 Gene discovery could lead to male contraceptive

Enlarge

Mouse studies have shown that the CATSPER1 gene is present in sperm and is essential for normal sperm motion during fertilization. The left side of the diagram illustrates normal sperm fertilizing an egg. The right side of the diagram illustrates that sperm lacking the CatSper1 protein are not able to penetrate an outer layer of the egg, known as the zona pellucida, preventing normal fertilization. Credit: University of Iowa. Image adapted from Avenarius et al 2009 AJHG in press.

A newly discovered genetic abnormality that appears to prevent some men from conceiving children could be the key for developing a male contraceptive, according to University of Iowa researchers reporting their findings in the April 2 online edition of the American Journal of Human Genetics.

Although female oral contraceptives were developed over 40 years ago and have proven very effective for family planning, no similar pharmacological contraceptive has been developed for males. Surveys conducted by the Medical Research Council Reproductive Biology Unit in the United Kingdom, suggest that men would be willing to use a pharmacological contraceptive if one was available. Presently the only contraceptives available for men are condoms or a vasectomy.

"We have identified CATSPER1 as a gene that is involved in non-syndromic male infertility in humans, a finding which could lead to future infertility therapies that replace the gene or the protein. But, perhaps even more importantly, this finding could have implications for male contraception," said Michael Hildebrand, Ph.D., co-lead author of the study and a UI postdoctoral researcher in otolaryngology at the UI Roy J. and Lucille A. Carver College of Medicine.

The research team, which included scientists from the University of Social Welfare and Rehabilitation Sciences in Tehran, Iran, discovered the male infertility gene while studying the genetics of families from Iran -- a population that has relatively high rates of disease-causing gene mutations.

Although the team's research with these Iranian families focuses on identifying genetic causes of deafness, collecting genetic information from this population allowed the researchers to identify two families where male infertility that was not part of a syndrome appeared to be inherited. The affected men's infertility was diagnosed with a routine semen analysis.

Focusing on a group of that have been implicated in male infertility in mice, the researchers found that mutations in both Iranian families occurred in a single gene called CATSPER1. DNA analysis revealed two different mutations -- one in each family -- but both mutations would likely lead to either a very truncated, non-functional version of the protein, or no protein at all. Neither mutation was found in the DNA of 576 Iranian individuals who were screened as controls.

Harvard University studies on mouse models that lack the CATSPER1 gene reveal how sperm is affected when the protein is missing or abnormal. These studies show that CATSPER1 mutations affect sperm motility, specifically the very vigorous hyperactive motion the sperm uses when it is entering the egg during fertilization.

"Our research suggests that the defect in sperm hyperactivity that is seen in mice without CATSPER1 will also occur in humans with the genetic mutation," Hildebrand said. "Identification of targets such as the CATSPER1 gene that are involved in the fertility process and are specific for sperm -- potentially minimizing side effects of a drug targeting the protein's function -- provide new targets for a pharmacological male contraceptive."

Several approaches to male contraception are currently under investigation at other institutions. One approach that could potentially target CATSPER1 is immunocontraception where antibodies are developed that bind to a targeted protein and block its function. Immunocontraception is still in early stages of development and in order to be useful it will need to be proven effective, safe and reversible.

Source: University of Iowa (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4 /5 (1 vote)


April 2, 2009 all stories

Comments: 0

4 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

The Link Between Birdsong And Human Language

The Link Between Birdsong And Human Language

Medicine & Health / Neuroscience

created 6 hours ago | popularity 4.8 / 5 (5) | comments 0

Scientists studying how Bengalese finches use sets of syllables to communicate are a step closer to understanding how humans develop and use vocabulary. After studying the neural networks in finch brains, ...


curly hair

Single gene may cause curly hair

Medicine & Health / Genetics

created 15 hours ago | popularity 4.8 / 5 (5) | comments 0

(PhysOrg.com) -- Scientists in Australia have identified a single gene that strongly influences whether you have curly or straight hair.


Drug shrinks lung cancer tumors in mice

Medicine & Health / Cancer

created 9 hours ago | popularity 4.8 / 5 (5) | comments 0

A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer tumours from growing and becoming resist ...


'Emotions increase or decrease pain': researchers

Medicine & Health / Research

created 11 hours ago | popularity 5 / 5 (2) | comments 0

Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine. According to a new Université de Montréal study, published in the latest ...


Drugs to treat anemia in cancer patients linked to thromboembolism

Medicine & Health / Cancer

created 5 hours ago | popularity 1 / 5 (1) | comments 1

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...